Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
0
Therma Bright Closing In On Fast COVID Test
Paul Archie
-
November 17, 2020
0
FDA Approves Landmark COVID/Heart/CBD Clinical Trial
Paul Archie
-
September 30, 2020
1
COVID-19
Home
COVID-19
COVID-19
Cardiol Therapeutics Receives FDA Approval For Investigational New Drug (IND) Application...
Paul Archie
-
September 25, 2020
0
COVID-19
China Biologic Products Falls Short of Q2 Expectations as COVID-19 Weighs
Andrew M.
-
August 20, 2020
0
COVID-19
Generex Announces Signed Agreement with Bintai Kinden to Advance the Clinical...
Generex Biotechnology Corporation
-
August 18, 2020
0
COVID-19
CytoDyn Submits its Top-line Report from its Phase 2 COVID-19 Trial...
CytoDyn Inc.
-
August 17, 2020
0
1
2
3
...
11
Page 1 of 11
- Advertisement -
LATEST NEWS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
CytoDyn Inc.
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
CytoDyn Inc.
-
February 22, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
CytoDyn Inc.
-
December 22, 2020
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva...
CytoDyn Inc.
-
December 8, 2020
LATEST INTERVIEWS
